NCT01631812View on ClinicalTrials.gov

A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Parkinson's Disease
Interventions
DRUG

SPM 962

SPM 962 transdermal patch once a daily up to 36.0 mg/day

Trial Locations (7)

Unknown

Chubu Region

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Shikoku Region

Tohoku Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

NCT01631812 - A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients | Biotech Hunter | Biotech Hunter